Insider Sales Rise Amid Xeris Biopharma Rally: What Investors Should Know
Inside Xeris Biopharma: Kevin McCulloch sells 25,000 shares at $10 amid an 18% rally, highlighting disciplined trading vs. investor caution.
- XERIS BIOPHARMA HOLDINGS INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read